The objective of this study was to identify factors related to the expansion of infection and prevention of influenza A(H1N1)pdm09. A retrospective non-randomized cohort study (from June 2009 to May 2010) on influenza A(H1N1)pdm09 was conducted in a sample of residents from Hiroshima Prefecture, Japan. The cumulative incidence of the influenza A(H1N1)pdm09 and the pandemic vaccine effectiveness (VE) were estimated. The response rate was 53.5% (178,669/333,892). Overall, the odds ratio of non-vaccinated group to vaccinated group for cumulative incidence of influenza A(H1N1)pdm09 was 2.18 (95% confidence interval (CI): 2.13–2.23) and the VE was 43.9% (CI: 42.8–44.9). The expansion of infection, indicating the power of transmission from infect...
While vaccination is the only established option to prevent a susceptible host from influenza, we ha...
BACKGROUND: During the influenza pandemic of 2009 estimates of symptomatic and asymptomatic infectio...
Background: Since 2007, trivalent inactivated influenza vaccine (TIV) has been provided free-of-char...
The objective of this study was to identify factors related to the expansion of infection and preven...
Abstract Background Influenza virus transmission may be prevented by infection control measures, inc...
<div><p>Enhanced influenza surveillance was implemented to analyze transmission dynamics particularl...
Background Children play an important role in maintaining the transmission of influenza. Evidence su...
Objective: The focus of this study was to ascertain the factors associated with 2009 pandemic influe...
Background: To date, few large-scale comparative effectiveness studies of influenza vaccination have...
During the influenza pandemic of 2009 estimates of symptomatic and asymptomatic infection were neede...
Influenza vaccination rates among Japanese people of working age (20–69 years) is currently suboptim...
Background: A worldwide outbreak of swine flu H1N1 pandemic influenza occurred in April 2009. To det...
Background. The objective of this retrospective descriptive study was to determine whether the unive...
Background and aim of the work: The global burden of disease attributable to seasonal influenza viru...
SummaryObjectiveThe focus of this study was to ascertain the factors associated with 2009 pandemic i...
While vaccination is the only established option to prevent a susceptible host from influenza, we ha...
BACKGROUND: During the influenza pandemic of 2009 estimates of symptomatic and asymptomatic infectio...
Background: Since 2007, trivalent inactivated influenza vaccine (TIV) has been provided free-of-char...
The objective of this study was to identify factors related to the expansion of infection and preven...
Abstract Background Influenza virus transmission may be prevented by infection control measures, inc...
<div><p>Enhanced influenza surveillance was implemented to analyze transmission dynamics particularl...
Background Children play an important role in maintaining the transmission of influenza. Evidence su...
Objective: The focus of this study was to ascertain the factors associated with 2009 pandemic influe...
Background: To date, few large-scale comparative effectiveness studies of influenza vaccination have...
During the influenza pandemic of 2009 estimates of symptomatic and asymptomatic infection were neede...
Influenza vaccination rates among Japanese people of working age (20–69 years) is currently suboptim...
Background: A worldwide outbreak of swine flu H1N1 pandemic influenza occurred in April 2009. To det...
Background. The objective of this retrospective descriptive study was to determine whether the unive...
Background and aim of the work: The global burden of disease attributable to seasonal influenza viru...
SummaryObjectiveThe focus of this study was to ascertain the factors associated with 2009 pandemic i...
While vaccination is the only established option to prevent a susceptible host from influenza, we ha...
BACKGROUND: During the influenza pandemic of 2009 estimates of symptomatic and asymptomatic infectio...
Background: Since 2007, trivalent inactivated influenza vaccine (TIV) has been provided free-of-char...